hepatitis.cl
English

Publicaciones del Dr. Alejandro Soza

Listado de las publicaciones científicas del Dr. Alejandro Soza en revistas nacionales e internacionales, con enlaces al texto completo y a su indexación.

Esta es la lista de publicaciones científicas del Dr. Alejandro Soza en revistas nacionales e internacionales, ordenada desde la más reciente. El título enlaza al texto completo cuando está disponible.

También puede consultar el listado actualizado en PubMed.

  1. Idalsoaga F, Díaz LA, Blaney H, Picchio C, Contreras F, Ricouz B, Salinas D, Espinoza V, Venegas P, Harfagar M, Santander I, Medel MP, Ramirez-Cadiz C, Arrese M, Soza A, Oudshoorn A, Arab JP. Hepatitis C among people experiencing homelessness in Chile: prevalence and associated factors. Rev Gastroenterol Peru. 2026;46(2):138-143. doi: 10.47892/rgp.2026.462.2241.

  2. Lamadrid A, Leiva-Escobar I, Soza A, Quentin W. Impact of the COVID-19 pandemic on hepatitis C care across the cascade of care: a scoping review. BMC Infect Dis. 2026 Jun 13;26(1):1139. doi: 10.1186/s12879-026-13799-1. PMID: 42288770.

  3. Uribe J, Pérez-Valenzuela J, Astudillo P, Vargas JI, Benítez C, López-Lastra M, Núñez R, Soza J, Pino K, Fuster F, Soza A. High hepatitis B exposure and HIV prevalence but no evidence of HDV among Haitian migrants in Chile: A cross-sectional study. J Infect Public Health. 2026 Feb;19(2):103054. doi: 10.1016/j.jiph.2025.103054. PMID: 41274071.

  4. Pessoa MG, Hernandez N, Castro Narro G, Mattos AA, Silva M, Soza A, Dagher L, Padilla-Machaca M, Garavito-Rentería J, Hernández Blanco J, Cheinquer H, Gadano A, Ridruejo E; Latin American Association for the Study of the Liver (ALEH). ALEH position statement on the management of hepatitis B virus infection 2025. Ann Hepatol. 2026 Jan 30;31(2):102192. doi: 10.1016/j.aohep.2026.102192. PMID: 41621642.

  5. Crespo J, Calleja JL, Ridruejo E, Alonso-Peña M, Cabezas J, Castro-Narro GE, Hernandez N, Cheinquer H, Contreras F, Perelló C, Mendizabal M, Cairo F, Guimarães Pessôa M, Emerim E, Guerra Salazar P, Zapata R, Soza A, Nazal Ortiz LM, Beltran-Galvis OA, Hernández-Blanco J, Garzón M, Coste P, Alvarado Salazar M, Infante-Velázquez M, Carrera Estupiñán E, Mora J, Valdez de Cuellar M, Moreno JM, Velarde-Ruiz Velasco JA, Mayorga Marin T, Mayo MA, Adames E, Girala M, Garavito-Rentería J, Rodríguez Romero K, Rodríguez-Perez F, Galloso Gentille R, Dagher L, Mainardi V. Overcoming barriers to HCV screening in Latin America: From evidence to action. Ann Hepatol. 2026 Jan 18;31(2):102189. doi: 10.1016/j.aohep.2026.102189. PMID: 41558550.

  6. Mendizabal M, Sabate CD, González Ballerga E, Gruz F, Ridruejo E, Soza A, Poniachik J, Vergara G, Mainardi V, Mezzano G, Bessone F, Anders M, Pessoa MG, Cairo F, Chiodi D, Dirchwolf M, Cheinquer H, Susana M, Rondeau L, Rifrani G, Aguirre H, Hernandez N, Enrique C, Navarro L, Labaronnie E, Zitelli PM, de Araujo A, Olivetti A, Simian D, Giunta D, Silva M, Marciano S. Increasing Treatment Uptake for Chronic Hepatitis B in South America: A Comparative Analysis of Country-Specific and WHO 2024 Guidelines. J Viral Hepat. 2025 Jun;32(6):e70035. doi: 10.1111/jvh.70035. PMID: 40418118.

  7. Crespo J, Cabezas J, Castro-Narro G, Cheinquer H, Contreras F, Hernandez N, Perelló C, Ridruejo E, Calleja JL; REVIRAL Project (Alejandro Soza, group member). REVIRAL: roadmap for the elimination of viral hepatitis in Latin America. Front Public Health. 2025 May 16;13:1527704. doi: 10.3389/fpubh.2025.1527704. PMID: 40453491.

  8. Muñoz A, Espino A, Soza A, Arenas A, Gran J, Norero B. Acceptability and screening outcomes for hepatitis B, C and human inmunodeficiency virus using rapid diagnostic tests in patients undergoing outpatient endoscopy. Rev Gastroenterol Peru. 2024 Oct-Dec;44(4):354-358. PMID: 39825812.

  9. Díaz LA, Villalón A, Ochoa G, García S, Severino N, Ayares G, Idalsoaga F, Dib M, Briceño E, Viñuela E, Martinez J, Jarufe N, Rabagliati R, Meneses L, Muñoz-Schuffenegger P, Vargas JI, Espino A, Vera MM, Benítez C, Wolff R, Norero B, Barrera F, Soza A, Arrese M, Arab JP. Updates in General Management and Frequent Complications Following Adult Liver Transplant. Rev Med Chil. 2024 Jun;152(6):704-717. doi: 10.4067/S0034-98872024000600704. PMID: 39760565.

  10. Piñero F, Costentin C, Degroote H, Notarpaolo A, Boin IF, Boudjema K, Baccaro C, Chagas A, Bachellier P, Ettorre GM, Poniachik J, Muscari F, Dibenedetto F, Duque SH, Salame E, Cillo U, Marciano S, Vanlemmens C, Fagiuoli S, Carrilho F, Cherqui D, Burra P, Van Vlierberghe H, Lai Q, Silva M, Rubinstein F, Duvoux C; collaborative group for HCC and liver transplantation; France; Latin America; Italy; Belgium. AFP score and metroticket 2.0 perform similarly and could be used in a “within-ALL” clinical decision tool. JHEP Rep. 2022 Dec 5;5(2):100644. doi: 10.1016/j.jhepr.2022.100644. eCollection 2023 Feb. PMID: 36691474.

  11. Mendizabal M, Thompson M, Gonzalez-Ballerga E, Anders M, Castro-Narro GE, Pessoa MG, Cheinquer H, Mezzano G, Palazzo A, Ridruejo E, Descalzi V, Velarde-Ruiz Velasco JA, Marciano S, Muñoz L, Schinoni MI, Poniachik J, Perazzo R, Cerda E, Fuster F, Varon A, García SR, Soza A, Cabrera C, Gomez-Aldana AJ, de María Beltrán F, Gerona S, Cocozzella D, Bessone F, Hernández N, Alonso C, Ferreiro M, Antinucci F, Torre A, Moutinho BD, Coelho Borges S, Gomez F, Murga MD, Piñero F, Sotera GF, Ocampo JA, Cortés Mollinedo VA, Simian D, Silva MO. Implementation of a re-linkage to care strategy in patients with chronic hepatitis C who were lost to follow-up in Latin America. J Viral Hepat. 2022 Oct 5. doi: 10.1111/jvh.13758. Epub ahead of print. PMID: 36197907.

  12. Costentin C, Piñero F, Degroote H, Notarpaolo A, Boin IF, Boudjema K, Baccaro C, Podestá LG, Bachellier P, Ettorre GM, Poniachik J, Muscari F, Dibenedetto F, Duque SH, Salame E, Cillo U, Marciano S, Vanlemmens C, Fagiuoli S, Burra P, Van Vlierberghe H, Cherqui D, Lai Q, Silva M, Rubinstein F, Duvoux C; French-Italian-Belgium and Latin American collaborative group for HCC and liver transplantation. R3-AFP score is a new composite tool to refine prediction of hepatocellular carcinoma recurrence after liver transplantation. JHEP Rep. 2022 Feb 2;4(5):100445. doi: 10.1016/j.jhepr.2022.100445. eCollection 2022 May. PMID: 35360522.

  13. Vargas JI, Rivera K, Arrese M, Benitez C, Barrera F, Hugo M, Arab JP, Pino K, Barrera A, Lopez-Lastra M, Rigotti A, Soza A. LDL particle size and antioxidant HDL function improve after sustained virological response in patients with chronic HCV. Ann Hepatol. 2022 Jan-Feb;27(1):100555. doi: 10.1016/j.aohep.2021.100555. Online ahead of print. PMID: 34626827.

  14. Degroote H, Piñero F, Costentin C, Notarpaolo A, Boin IF, Boudjema K, Baccaro C, Chagas AL, Bachellier P, Ettorre GM, Poniachik J, Muscari F, Di Benedetto F, Duque SH, Salame E, Cillo U, Gadano A, Vanlemmens C, Fagiuoli S, Rubinstein F, Burra P, Cherqui D, Silva M, Van Vlierberghe H, Duvoux C; French-Italian-Belgium and Latin American collaborative group for HCC and liver transplantation. International study on the outcome of locoregional therapy for liver transplant in hepatocellular carcinoma beyond Milan criteria. JHEP Rep. 2021 Jul 13;3(5):100331. doi: 10.1016/j.jhepr.2021.100331. eCollection 2021 Oct. PMID: 34485882.

  15. Vargas JI, Jensen D, Martínez F, Sarmiento V, Peirano F, Acuña P, Provoste F, Bustos V, Cornejo F, Fuster A, Acuña M, Fuster F, Soto S, Estay D, Jensen W, Ahumada R, Arab JP, Soza A, Fuster F. Comparative Efficacy of a High-Dose vs Standard-Dose Hepatitis B Revaccination Schedule Among Patients With HIV: A Randomized Clinical Trial. JAMA Netw Open. 2021 Aug 2;4(8):e2120929. doi: 10.1001/jamanetworkopen.2021.20929. PMID: 34424307.

  16. Zapata R, Mezzano G, Soza A, Gómez F, Izquierdo G, Zamora F, Muñoz MP, Peña A. Orientación técnica: manejo y tratamiento de la infección por virus de la hepatitis B (VHB) Chile. Gastroenterol Latinoam. 2021. 32(2):49-77. Texto completo

  17. Piñero F, Anders M, Boin IF, Chagas A, Quiñonez E, Marciano S, Vilatobá M, Santos L, Hoyos Duque S, Lima AS, Menendez J, Padilla M, Poniachik J, Zapata R, Soza A, Maraschio M, Chong Menéndez R, Muñoz L, Arufe D, Figueroa R, de Ataide EC, Maccali C, Vergara Sandoval R, Bermudez C, Podesta LG, McCormack L, Varón A, Gadano A, Mattera J, Villamil F, Rubinstein F, Carrilho F, Silva M. Liver transplantation for hepatocellular carcinoma: impact of expansion criteria in a multicenter cohort study from a high waitlist mortality region. Transpl Int. 2021 Jan;34(1):97-109. doi: 10.1111/tri.13767. PMID: 33040420.

  18. Homie Razavi, Sarah Blach, Devin Razavi-Shearer, The Polaris Observatory Collaborators. The case for simplifying and using absolute targets for viral hepatitis elimination goals. J Viral Hepat. 2021 Jan;28(1):12-19. doi: 10.1111/jvh.13412. PMID: 32979881.

  19. Díaz LA, Idalsoaga F, Cannistra M, Candia R, Cabrera D, Barrera F, Soza A, Graham R, Riquelme A, Arrese M, Leise MD, Arab JP. High prevalence of hepatic steatosis and vascular thrombosis in COVID-19: A systematic review and meta-analysis of autopsy data. World J Gastroenterol. 2020 Dec 28;26(48):7693-7706. doi: 10.3748/wjg.v26.i48.7693. PMID: 33505145.

  20. Fuster F, Peirano F, Vargas JI, Zamora FX, López-Lastra M, Núñez R, Soza J, González K, Estay D, Barchiesi B, Fuster A, López I, Utrera N, Landeros J, Chandía J, Paredes A, Reyes D, Arias R, Padilla L, Suárez H, Farcas K, Cannistra M, Muñoz G, Rodríguez I, Ormazábal I, Cortés J, Cornejo B, Manzur F, Reyes A, Leiva V, Raimann MV, Arrau C, Cox V, Soza A. Infectious and non-infectious diseases burden among Haitian immigrants in Chile: a cross-sectional study. Sci Rep. 2020 Dec 17;10(1):22275. doi: 10.1038/s41598-020-78970-3. PMID: 33335156.

  21. Maccali C, Chagas AL, Boin I, Quiñonez E, Marciano S, Vilatobá M, Varón A, Anders M, Hoyos Duque S, Lima AS, Menendez J, Padilla-Machaca M, Poniachik J, Zapata R, Maraschio M, Chong Menéndez R, Muñoz L, Arufe D, Figueroa R, Soza A, Fauda M, Perales SR, Vergara Sandoval R, Bermudez C, Beltran O, Arenas Hoyos I, McCormack L, Mattera FJ, Gadano A, Parente García JH, Tani CM, Augusto Carneiro D’Albuquerque L, Carrilho FJ, Silva M, Piñero F. Recurrence of hepatocellular carcinoma after liver transplantation: Prognostic and predictive factors of survival in a Latin American cohort. Liver Int. 2020 Nov 20. doi: 10.1111/liv.14736. Online ahead of print. PMID: 33217193.

  22. Ridruejo E, Piñero F, Mendizabal M, Cheinquer H, Wolff FH, Anders M, Reggiardo V, Ameigeiras B, Palazzo A, Alonso C, Schinoni MI, Zuain MGV, Tanno F, Figueroa S, Santos L, Peralta M, Soza A, Vistarini C, Adrover R, Fernández N, Perez D, Hernández N, Estepo C, Bruno A, Descalzi V, Sixto M, Borzi S, Cocozzella D, Zerega A, de Araujo A, Varón A, Silva M; Latin American Liver Research Educational and Awareness Network (LALREAN). Decompensated cirrhosis and liver transplantation negatively impact in DAA treatment response: Real-world experience from HCV-LALREAN cohort. J Med Virol. 2020 Aug 4. doi: 10.1002/jmv.26383. PMID: 32749710.

  23. Ridruejo E, Soza A. The liver in times of COVID-19: What hepatologists should know. Ann Hepatol. Jul-Aug 2020;19(4):353-358. doi: 10.1016/j.aohep.2020.05.001. Online ahead of print. PMID: 32425991.

  24. Gaete MI, Díaz LA, Arenas A, González K, Cattaneo M, Fuster F, Henríquez R, Soza A, Arrese M, Barrera F, Arab JP, Benítez C. Baveno VI and Expanded Baveno VI criteria successfully predicts the absence of high‐risk gastro‐oesophageal varices in a Chilean cohort. Liver Int. 2020 Jun;40(6):1427-1434. doi: 10.1111/liv.14373. Epub 2020 Jan 22. PMID: 31916360.

  25. Mendizabal M, Piñero F, Ridruejo E, Wolff FH, Anders M, Reggiardo V, Ameigeiras B, Palazzo A, Alonso C, Schinoni MI, Videla Zuain MG, Tanno F, Figueroa S, Santos L, Peralta M, Soza A, Vistarini C, Adrover R, Fernández N, Perez D, Hernández N, Estepo C, Bruno A, Descalzi V, Sixto M, Borzi S, Cocozzella D, Zerega A, de Araujo A, Varón A, Rubinstein F, Cheinquer H, Silva M. Disease Progression in Patients With Hepatitis C Virus Infection Treated With Direct-acting Antiviral Agents. Clin Gastroenterol Hepatol. 2020 Feb 27. pii:S1542-3565(20)30263-9. doi: 10.1016/j.cgh.2020.02.044. PMID: 32113892.

  26. Arcos M, Ruiz M, Fuentes-López E, Álvarez D, Duarte I, Arrese M, Riquelme A, Soza A. Chlamydophila pneumoniae infection is not associated with primary biliary cholangitis. Gastroenterol Latinoam. 2019; 30(2):58-63.

  27. Piñero F, Mendizabal M, Ridruejo E, Herz Wolff F, Ameigeiras B, Anders M, Schinoni MI, Reggiardo V, Palazzo A, Videla M, Alonso C, Santos L, Varón A, Figueroa S, Vistarini C, Adrover R, Fernández N, Perez D, Tanno F, Hernández N, Sixto M, Borzi S, Bruno A, Cocozzella D, Soza A, Descalzi V, Estepo C, Zerega A, de Araujo A, Cheinquer H, Silva M; LALREAN. Treatment with direct-acting antivirals for HCV decreases but does not eliminate the risk of hepatocellular carcinoma. Liver Int. 2019 Jun;39(6):1033-1043. doi: 10.1111/liv.14041. Epub 2019 Feb 4. PMID: 30636361.

  28. Ridruejo E, Soza A. Which Strategies Should Be Implemented in Latin America to Eradicate Hepatitis C Virus by 2030?. Clin Liver Dis (Hoboken). 2019 Mar 4;13(2):43-45. doi: 10.1002/cld.771. eCollection 2019 Feb. PMID: 31139354.

  29. Guerra JF, Troncoso A, Ceballos ME, Arrese M, Barrera F, Norero B, Soza A, Rivas V, Wolff R, Arias A, Cancino A, Torres J, Briceño E, Jarufe N, Martínez J, Benítez C. Liver transplantation in a patient with human immunodeficiency virus (HIV). Case report. Rev Med Chil. 2018 Dec;146(10):1215-1219. doi: 10.4067/S0034-98872018001001215. PMID: 30724988.

  30. Piñero F, Costa P, Boteon YL, Duque SH, Marciano S, Anders M, Varón A, Zerega A, Poniachik J, Soza A, Padilla Machaca M, Menéndez J, Zapata R, Vilatoba M, Muñoz L, Maraschio M, Podestá LG, McCormack L, Gadano A, Boin ISFF, García P, Silva M; Latin American Liver Research, Education, Awareness Network (LALREAN). A changing etiologic scenario in liver transplantation for hepatocellular carcinoma in a multicenter cohort study from Latin America. Clin Res Hepatol Gastroenterol. 2018 Oct;42(5):443-452. doi: 10.1016/j.clinre.2018.03.014. PubMed PMID: 29773419.

  31. Rivas V, Barrera A, Pino K, Núñez R, Caceres CJ, Lopez-Lastra M, Soza A. Hepatitis A outbreak since November 2016 affecting men who have sex with men (MSM) in Chile connected to the current outbreak in MSM in Europe, situation up to October 2017. Euro Surveill. 2018 Mar;23(9). doi: 10.2807/1560-7917.ES.2018.23.9.18-00060. PMID: 29510780.

  32. Piñero F, Costa P, Boteon YL, Duque SH, Marciano S, Anders M, Varón A, Zerega A, Poniachik J, Soza A, Machaca MP, Menéndez J, Zapata R, Vilatoba M, Muñoz L, Maraschio M, Fauda M, McCormack L, Gadano A, Boin IS, García JHP, Silva M. Results of Liver Transplantation for Hepatocellular Carcinoma in a Multicenter Latin American Cohort Study. Ann Hepatol. 2018 Mar 1;17(2):256-267. doi: 10.5604/01.3001.0010.8648. PMID: 29469048.

  33. Vargas JI, Arab JP, Monrroy H, Labbé P, Sarmiento V, Fuster F, Barrera F, Benitez C, Arrese M, Fuster F, Soza A. Direct antivirals for the treatment of chronic hepatitis C virus infection. Experience in 106 patients. Rev Med Chil. 2017 Oct;145(10):1235-1242. doi: 10.4067/S0034-98872017001001235. PMID: 29488563.

  34. Arab JP, Hernández-Rocha C, Morales C, Vargas JI, Solís N, Pizarro M, Robles C, Sandoval D, Ponthus S, Benítez C, Barrera F, Soza A, Riquelme A, Arrese M. Serum cytokeratin-18 fragment levels as noninvasive marker of nonalcoholic steatohepatitis in the chilean population. Gastroenterol Hepatol. 2017 Jun - Jul;40(6):388-394. doi: 10.1016/j.gastrohep.2017.02.009. Epub 2017 Mar 28. PMID: 28359548.

  35. Mendizabal M, Haddad L, Gallardo PE, Ferrada A, Soza A, Adrover R, Aravena E, Roblero JP, Prieto J, Vujacich C, Romero G, Muñoz A, Anders M, Hernández N, Coccozella D, Gruz F, Reggiardo MV, Ruf AE, Varón A, Cartier M, Pérez Ravier R, Ridruejo E, Peralta M, Poncino D, Vorobioff J, Aballay Soteras G, Silva MO. Ombitasvir/paritaprevir/ritonavir/dasabuvir ± ribavirin is safe and effective in HCV-infected patients in a real-life cohort from Latin America. J Med Virol. 2017 Sep;89(9):1590-1596. doi: 10.1002/jmv.24816. Epub 2017 Jun 6. PMID: 28370222.

  36. Solari S, Cancino A, Wolff R, Norero B, Vargas JI, Barrera F, Guerra JF, Martínez J, Jarufe N, Soza A, Arrese M, Benitez C. Sublingual tacrolimus administration provides similar drug exposure to per-oral route employing lower doses in liver transplantation: a pilot study. Aliment Pharmacol Ther. 2017 May;45(9):1225-1231. doi: 10.1111/apt.14022. Epub 2017 Mar 6. PMID: 28261844.

  37. Vargas C, Espinoza MA, Giglio A, Soza A. Estudio de impacto presupuestal de Daclatasvir asociado a Asunaprevir para el tratamiento de la Hepatitis C desde la perspectiva del sistema de salud público chileno. Value in Health Regional Issues. 2017. 14:28-32. https://doi.org/10.1016/j.vhri.2017.03.005. PMID: 29254538.

  38. Candia R, Norero B, Agüero C, Díaz L, Ortega JP, Wolff R, Hernández-Rocha C, Duarte I, Soza A, Benítez C, Arrese M. Validation of the Simplified Criteria for the Diagnosis of Autoimmune Hepatitis in Chilean-Hispanic Patients. Ann Hepatol. 2017 Sep-Oct;16(5):772-779. doi: 10.5604/01.3001.0010.2787. PMID: 28809732.

  39. Monrroy H, López-Lastra M, Soza A. Hepatitis C virus may have an entero-hepatic cycle which could be blocked with ezetimibe. Med Hypotheses. 2017 May;102:51-55. doi: 10.1016/j.mehy.2017.03.016. PMID: 28478831.

  40. Monrroy H, Angulo J, Pino K, Labbé P, Miquel JF, López-Lastra M, Soza A. Detection of high biliary and fecal viral loads in patients with chronic hepatitis C virus infection. Gastroenterol Hepatol. 2017 May;40(5):339-347. doi: 10.1016/j.gastrohep.2017.01.004. PMID: 28249699.

  41. Norero B, Serrano CA, Sanchez-Fueyo A, Duarte I, Torres J, Ocquetau M, Barrera F, Arrese M, Soza A, Benítez C. Conversion to mycophenolate mofetil monotherapy in liver recipients: Calcineurin inhibitor levels are key. Ann Hepatol. 2017 Jan-Feb 2017;16(1):94-106. doi: 10.5604/16652681.1226820. PMID: 28051798.

  42. Piñero F, Tisi Baña M, de Ataide EC, Hoyos Duque S, Marciano S, Varón A, Anders M, Zerega A, Menéndez J, Zapata R, Muñoz L, Padilla Machaca M, Soza A, McCormack L, Poniachik J, Podestá LG, Gadano A, Boin IS, Duvoux C, Silva M; Latin American Liver Research, Education and Awareness Network (LALREAN). Liver Transplantation for Hepatocellular carcinoma: Evaluation of the AFP model in a multicenter cohort from Latin America. Liver Int. 2016. Nov;36(11):1657-1667. PMID: 27169841.

  43. Monrroy-Bravo H, Angulo J, Pino K, Labbé P, López-Lastra M, Soza A. Effect of ezetimibe in HCV viral load after liver transplantation. Ann Hepatol. 2016. Sep-Oct;15(5):803-5. PMID: 27493122.

  44. Dore GJ, Conway B, Luo Y, Janczewska E, Knysz B, Liu Y, Streinu-Cercel A, Caruntu FA, Curescu M, Skoien R, Ghesquiere W, Mazur W, Soza A, Fuster F, Greenbloom S, Motoc A, Arama V, Shaw D, Tornai I, Sasadeusz J, Dalgard O, Sullivan D, Liu X, Kapoor M, Campbell A, Podsadecki T. Efficacy and safety of ombitasvir/paritaprevir/r and dasabuvir compared to IFN-containing regimens in genotype 1 HCV patients: The MALACHITE-I/II trials. J Hepatol. 2016 Jan;64(1):19-28. PMID: 26321288.

  45. Ruiz A, Soza A. Tratamiento de la hepatitis C en cirrosis: beneficios y riesgos. Gastr Latinoam 2016; Vol 27, Supl Nº 1: S 64-S 68.

  46. Vargas CL, Espinoza MA, Giglio A, Soza A. Cost Effectiveness of Daclatasvir/Asunaprevir Versus Peginterferon/Ribavirin and Protease Inhibitors for the Treatment of Hepatitis C Genotype 1b Naïve Patients in Chile. PLoS One. 2015 Nov 6;10(11):e0141660. PMID: 26544203.

  47. Pizarro M, Solís N, Rojas V, Díaz LA, Padilla O, Letelier LM, Aizman A, Sarfatis A, Olivos T, Soza A, Delfino A, Latorre G, Ivanovic-Zuvic D, Hoyl T, Bitran M, Arab JP, Riquelme A. Development of MEDUC-PG14 survey to assess postgraduate teaching in medical specialties. Rev Med Chil. 2015 Aug;143(8):1005-1014. PMID: 26436929.

  48. *Rivera MM, *Soza A, Jazwinski A, Mi L, Kleiner DE, Zhao X, Zuber C, Brust D, Hsu E, Simpson J, Hoofnagle JH, Heller T. HIV Through the looking glass: Insights derived from hepatitis B. J Acquir Immune Defic Syndr. 2015 Feb 1;68(2):123-7. (*Contributed equally). PMID: 25590267.

  49. Soza A, Labbé P, Arrese M, Riquelme A, Barrera F, Benítez C, Huete A, Balcells ME, Labarca J. Mycobacterium abscessus pulmonary infection during hepatitis C treatment with telaprevir, peginterferon and ribavirin. Ann Hepatol. 2015. Jan-Feb;14(1):132-6. PMID: 25536652.

  50. Arab JP, Candia R, Zapata R, Muñoz C, Arancibia JP, Poniachik J, Soza A, Fuster F, Brahm J, Sanhueza E, Contreras J, Cuellar MC, Arrese M, Riquelme A. Management of nonalcoholic fatty liver disease: an evidence-based clinical practice review. World J Gastroenterol. 2014 Sep 14;20(34):12182-201. PMID: 25232252.

  51. Méndez-Sánchez N, Paraná R, Cheinquer H, Alves de Mattos A, Gadano A, Silva M, Pessôa MG, Gomes-Ferraz ML, Soza A, Mendes-Correa MC, Chávez-Tapia NC, Dagher L, Padilla M, Hernandez N, Sánchez-Avila JF, Contreras F, Moraes-Coelho HS, Parise ER, Bessone F, Uribe M. Latin American Association for the Study of the Liver: Recommendations on treatment of hepatitis C. Ann Hepatol. 2014 Aug;13 Suppl 2:1-66. PMID: 25185535.

  52. Norero B, Pérez-Ayuso RM, Duarte I, Ramirez P, Soza A, Arrese M, Benítez C. Portal hypertension and acute liver failure as uncommon manifestations of primary amyloidosis. Ann Hepatol. 2014;13(1):142-9. PMID: 24378278.

  53. Pérez G, Candia R, Barrera F, Soza A. Sofosbuvir para infección crónica por virus de hepatitis C previamente no tratada. Gastroenterol. latinoam 2014; Vol 25, Nº 1: 55-58.

  54. Gabrielli M, Galindo JL, Figueroa E, Moisan F, Arrese M, Benítez C, Soza A, Domínguez P, Pérez RM, Guerra JF, Jarufe N, Martínez J. Trasplante hepático en pacientes con trombosis de la vena porta. Rev. Chilena de Cirugía. 2013;62(2):139-145.

  55. Ruiz A, Pérez G, Soza A. Tratamiento de infección por virus de hepatitis C mediante secuestro de ARNm. Gastr Latinoam 2013; Vol 24, Nº 3: 168-171.

  56. Soza A, Lopez-Lastra M. IL28B Polymorphisms Among Latin American HCV Patients. Curr Hepatitis Rep. 2013;12:276–279.

  57. Chávez-Tapia NC, Ridruejo E, Alves de Mattos A, Bessone F, Druich J, Sánchez-Avila JF, Cheinquer H, Zapata R, Uribe M, Bosques-Padilla F, Gadano A, Soza A, Dávalos-Moscol M, Marroni C, Muñoz-Espinoza L, Castro-Narro G, Paraná R, Méndez-Sánchez N. An update on the management of hepatitis C: guidelines for protease inhibitor-based triple therapy from the Latin American Association for the Study of the Liver. Ann Hepatol. 2013;12(2):S3-S35. PMID: 23559487.

  58. Angulo J, Pino K, Pavez C, Biel F, Labbé P, Miquel JF, Soza A, López-Lastra M. Genetic variations in host IL28B links to the detection of peripheral blood mononuclear cells-associated hepatitis C virus RNA in chronically infected patients. J Viral Hepat. 2013 Apr;20(4):263-72. PMID: 23490371.

  59. Gabrielli M, Moisan F, Vidal M, Duarte I, Jiménez M, Izquierdo G, Domínguez P, Méndez J, Soza A, Benitez C, Pérez R, Arrese M, Guerra J, Jarufe N, Martínez J. Steatotic livers. Can we use them in OLTX? Outcome data from a prospective baseline liver biopsy study. Ann Hepatol. 2012;11(6):891-8. PMID: 23109453.

  60. Soza A. Hepatitis C RNA clearance after treatment with ezetimibe. Liver Int. 2012;32(8):1323-4. PMID: 22775777.

  61. Manns MP, Gane E, Rodriguez-Torres M, Stoehr A, Yeh CT, Marcellin P, Wiedmann RT, Hwang PM, Caro L, Barnard RJ, Lee AW; for the MK-7009 Protocol 007 Study Group. Vaniprevir with peginterferon alfa-2a and ribavirin in treatment-naive patients with chronic hepatitis C - a randomized phase 2 study. Hepatology. 2012 56(3):884-893. PMID: 22473713.

  62. Benítez C, Arancibia JP, Arrese M, Soza A, Domínguez P, Jarufe N, Martínez J, Pérez-Ayuso RM. Operational tolerance after liver transplantation, more common than we think: A case report. Ann Hepatol. 2011;10(3):361-4. PMID: 21677341.

  63. Soza A. Aproximación al paciente con hepatitis C que ha fallado al tratamiento antiviral. Gastr Latinoam 2011; Vol 22, Nº 2: 148-151.

  64. Salech F, Valderrama S, Nervi B, Rodríguez JC, Oksenberg D, Koch A, Smok G, Duarte I, Pérez-Ayuso RM, Jarufe N, Martínez J, Soza A, Arrese M, Riquelme A. Thalidomide for the treatment of metastatic hepatic epithelioid hemangioendothelioma: a case report with a long term follow-up. Ann Hepatol. 2011; 3;10(1):99-102. PMID: 21301019.

  65. Arrese M, Riquelme A, Soza A. Insulin resistance, hepatic steatosis and hepatitis C: a complex relationship with relevant clinical implications. Ann Hepatol. 2010;9 Suppl:112-118. PMID: 20714007.

  66. Soza A, Riquelme A, Arrese M. Routes of transmission of hepatitis C virus. Ann Hepatol. 2010;9 Suppl:30-33. PMID: 20713992.

  67. Latin American Association for the Study of the Liver. Latin American Association for the Study of the Liver Practice Guidelines. Diagnosis, management, and treatment of hepatitis C. Ann Hepatol. 2010;9 Suppl:8-26. PMID: 20713990.

  68. Barrera F, Soza A. Shortened therapy for genotype 1 hepatitis C virus. The final answer?. Ann Hepatol. 2010;9(1):112-3. PMID: 20308734.

  69. Gabrielli M, Norero E, Figueroa E, Cortés P, Pimentel F, Huete A, Meneses L, Loyola S, Arrese M, Soza A, Pérez RM, Domínguez P, Guerra JF, Jarufe N, Martínez J. Incidencia, factores de riesgo y tratamiento de las complicaciones biliares del trasplante hepático. Rev. Chilena de Cirugía. 2010;62(4):355-361.

  70. Rotman Y, Borg BB, Soza A, Feld JJ, Modi AA, Loomba R, Lutchman G, Rivera E, Doo E, Ghany MG, Heller T, Neumann AU, Liang TJ, Hoofnagle JH. Clinical trial: low- and standard-dose peginterferon alfa-2a for chronic hepatitis C, genotype 2 or 3 - efficacy, tolerability, viral kinetics and cytokine response. Aliment Pharmacol Ther. 2010; 31(9):1018-27. PMID: 20163377.

  71. Caneo C, González M, Repetto P, Soza A. Trastornos psiquiátricos y cognitivos de la hepatitis C y su tratamiento con interferón. Rev Med Chile 2010;138:1431-40. PMID: 21279258.

  72. Gabrielli M, Vivanco M, Hepp J, Martínez J, Pérez R, Guerra J, Arrese M, Figueroa E, Soza A, Yáñes R, Humeres R, Rios H, Palacios JM, Zapata R, Sanhueza E, Contreras J, Rencoret G, Rossi R, Jarufe N. Liver transplantation results for hepatocellular carcinoma in Chile. Transplant Proc. 2010;42(1):299-301. PMID: 20172336.

  73. Vivanco M, Gabrielli M, Jarufe N, Humeres R, Rios H, Palacios JM, Zapata R, Sanhueza E, Contreras J, Rencore G, Rossi R, Martínez J, Pérez R, Guerra J, Arrese M, Figueroa E, Soza A, Yáñes R, Hepp J. Bridge therapy in hepatocellular carcinoma before liver transplantation: the experience of two Chilean centers. Transplant Proc. 2010;42(1):296-8. PMID: 20172335.

  74. Soza A, Palma R. Requisitos para la acreditación de centros y programas universitarios en gastroenterología. Gastr Latinoam 2010;21(4):502-9.

  75. Nazal L, Barría P, Acuña D, Rivas A, Vera N, Valiente D, Jiménez J, Cudworth M, Barra L, Contreras A, Salas I, Alvarez M, Soza A, Riquelme A. Alteración de pruebas hepáticas en pacientes chilenos con enfermedades hepáticas agudas y crónicas. Gastr Latinoam 2010:21(4):459-67.

  76. Riquelme A, de la Fuente P, Méndez B, Salech F, Valderrama S, Méndez JI, Oporto J, Miquel JF, Defilippi C, Soza A, Sirham M, Sáenz R. Identificación de las competencias del gastroenterólogo chileno: Técnica Delphi modificada. Gastr Latinoam 2010;21(4):437-53.

  77. Rojas C, Méndez L, Arab JP, Barrera F, Soza A, Nervi F, Duarte I, Pulgar MA, Paredes N, Molgó M, Amador R, Cariqueo M, Riquelme A. Síndrome de DRESS. Eritema cutáneo, fiebre y hepatitis asociado a lamotrigina. Reporte de dos casos y revisión de la literatura. Gastr Latinoam 2010;21(3):357-62.

  78. Soza A, San Martín AM, Jofré L, Noriega LM, Hunter B, Muñoz G, Becerra M, Martínez MC, Soto K, Rivera M, Tohá D. Guía clínica de manejo de la infección por virus de la Hepatitis C. Gastr Latinoam 2010;21(3):379-409.

  79. Arab JP, Pavez C, Soza A, Arrese MA, Riquelme A. Hepatitis colestásica por Mycoplasma pneumonia sin compromiso pulmonar. Caso clínico y revisión de la literature. Gastr Latinoam 2010;21(2):85-8.

  80. Soza A, Larraín S. Hepatotoxicidad por verapamil. Reporte de un caso. Gastr Latinoam. 2010;21(1):27-9.

  81. Castro F, Riquelme A, Accatino L, Huete A, Besa C, Velásquez C, Soza A. Fasciolasis hepática: Enfermedad con múltiples presentaciones. Gastr Latinoam. 2009;20(4):308-13.

  82. Barrera F, Riquelme A, Soza A, Contreras A, Barrios G, Padilla O, Viviani P, Pérez-Ayuso RM. Platelet count/spleen diameter ratio for non-invasive prediction of high risk esophageal varices in cirrhotic patients. Ann Hepatol. 2009;8(4):325-30. PMID: 20009131.

  83. Vera-Otarola J, Barría MI, León U, Carvallo P, Soza A, Marcelo López-Lastra M. Is single-strand conformation polymorphism analysis of the full 5’untranslated region an adequate approach to study hepatitis C virus quasispecies distribution?. Journal of Virology. 2009;83(17):9018-21. PMID: 19553315.

  84. Vera-Otarola J, Barrıa MI, Leon U, Marsac D, Carvallo P, Soza A, Lopez-Lastra M. Hepatitis C virus quasispecies in plasma and peripheral blood mononuclear cells of treatment naïve chronically infected patients. J Viral Hepat. 2009;16(9):633-43. PMID: 19254350.

  85. Barrıa MI, Gonzalez A, Vera-Otarola J, Leon U, Vollrath V, Marsac D, Monasterio O, Perez-Acle T, Soza A, Lopez-Lastra M. Analysis of natural variants of the hepatitis C virus internal ribosome entry site reveals that primary sequence plays a key role on cap-independent translation. Nucleic Acids Research. 2009;37(3):957-71. PMID: 19106142.

  86. Riquelme A, Arrese M, Soza A, Morales A, Baudrand R, Pérez-Ayuso RM, González R, Alvarez M, Hernández V, García-Zattera MJ, Otarola F, Medina B, Rigotti A, Miquel JF, Marshall G, Nervi F. Non-alcoholic fatty liver disease and its association with obesity, insulin resistance and increased serum levels of C-reactive protein in Hispanics. Liver Int. 2009;29(1):82-8. PMID: 18647235.

  87. Barría MI, Vera-Otarola J, León U, Vollrath V, Marsac D, Riquelme A, López-Lastra M, Soza A. Influence of extrahepatic viral infection on the natural history of hepatitis C. Ann Hepatol. 2008;7:136-43. PMID: 18626431.

  88. Soza A. Hepatitis autoinmune. Gastr Latinoam. 2007;18:193-7.

  89. Riquelme A, Soza A, Pedreros C, Bustamant A, Valenzuela F, Otarola F, Abbott E, Arellano M, Medina B, Pattillo A, Greig D, Arrese M, Rollan A. Optimal length of triple therapy for H pylori eradication in a population with high prevalence of infection in Chile. World J Gastroenterol. 2007;13:2967-72. PMID: 17589948.

  90. Cerda C, Perez-Ayuso RM, Riquelme A, Soza A, Villaseca P, Sir-Petermann T, Espinoza M, Pizarro M, Solis N, Miquel JF, Arrese M. Nonalcoholic fatty liver disease in women with polycystic ovary syndrome. J Hepatol. 2007;47:412-7. PMID: 17560682.

  91. Riquelme A, Calvo M, Salech F, Valderrama S, Pattillo A, Arellano M, Arrese M, Soza A, Viviani P, Letelier, LM. Value of adenosine deaminase (ADA) in ascitic fluid for the diagnosis of tuberculous peritonitis: A meta-analysis. J Clin Gastr. 2006;40:705–10. PMID: 16940883.

  92. Soza A, López-Lastra M. Hepatitis C en Chile: Magnitud del problema. Rev Med Chil. 2006;134:777-88. PMID: 17130955.

  93. Jarufe N, Soza A, Perez-Ayuso RM, Poblete JA, Gonzalez R, Guajardo M, Hernandez V, Riquelme A, Arrese M, Martınez J. Successful liver transplantation and delivery in a woman with fulminant hepatic failure occurring during the second trimester of pregnancy. Liver International. 2006;26:494–7. PMID: 16629654.

  94. Vial P, Riquelme A, Pizarro M, Solís M, Madariaga JM, Aguayo G, Duarte I, Soza A, Accatino L, Arrese M. Pentoxifylline does not prevent neither liver damage nor early profibrogenic events in a rat model of non-alcoholic steatohepatitis. Ann Hepatol. 2006;5:25-29. PMID: 16531961.

  95. Quinteros JI, Barrera F, Valderrama S, Salech F, Veas E, Espinoza M, Salas I, Soza A, Zárate V, Valdivia G, Bastías G, Riquelme A. Evaluación crítica de artículo económico: Análisis Costo-utilidad de estrategias de profilaxis secundaria en hemorragia variceal. Gastr Latinoam. 2006;17:86-98.

  96. Boza C, Riquelme A, Ibanez L, Duarte I, Norero E, Viviani P, Soza A, Fernandez JI, Raddatz A, Guzman S, Arrese M. Predictors of Nonalcoholic Steatohepatitis (NASH) in Obese Patients Undergoing Gastric Bypass. Obes Surg. 2005;15(8):1148-53. PMID: 16197788.

  97. Soza A, Riquelme A, Gonzalez R, Alvarez M, Perez-Ayuso RM, Glasinovic JC, Arrese M. Increased orocecal transit time in patients with nonalcoholic fatty liver disease. Dig Dis Sci. 2005;50:1136-40. PMID: 15986870.

  98. Salech F, Valderrama S, Espinoza M, Salas I, Veas E, Barrera F, Quinteros JI, Soza A, Letelier LM, Riquelme A. Evaluación de Test Diagnóstico. Utilidad de adenosin deaminasa (ADA) en el diagnóstico de peritonitis tuberculosa. Gastr Latinoam. 2005;16:262-268.

  99. Soza A, Heller T, Ghany M, G, Liang J, Germain J, Hsu HH, Park Y, Hoofnagle JH. Pilot study of interferon gamma for chronic hepatitis C. J Hepatol. 2005;43:67-71. PMID: 15913831.

  100. González R, Soza A, Hernández V, Pérez RM, Alvarez M, Morales A, Arrellano M, Riquelme A, Viviani P, Covarrubias C, Arrese M, Miquel JF, Nervi F. Incidence and prevalence of hepatitis C virus infection in Chile. Ann Hepatol. 2005;4:127-30. PMID: 16010246.

  101. Barrera F, Valderrama S, Salech F, Veas E, Espinoza M, Salas I, Quinteros JI, Soza A, Letelier LM, Riquelme A. Evaluación de meta-análisis: Utilidad de corticoides en el tratamiento de la hepatitis alcohólica grave. Gastr Latinoam. 2005;16:58-68.

  102. Soza A, Arrese M, González R, Alvarez M, Pérez RM, Cortés P, Patillo A, Riquelme A. Clinical and epidemiological features of 147 Chilean patients with chronic hepatitis C. Ann Hepatol. 2004;3:146-51. PMID: 15657556.

  103. Veas E, Barrera F, Salas I, Espinoza M, Quintero JI, Soza A, Letelier LM, Riquelme A. Evaluación de estudios de tratamiento: Utilidad de pentoxifilina en el tratamiento de la hepatitis por alcohol grave. Gastr Latinoam. 2004;15:208-218.

  104. Castillo C, Benítez C, Baccigaluppi G, Soza A, Riquelme A. Empiema bacteriano espontáneo en paciente cirrótico. Gastr Latinoam. 2004;15:203-7.

  105. Riquelme A, Soza A, Nazal L, Martínez G, Kolbach M, Patillo A, Arellano JM, Duarte I, Martínez J, Molgó M, Arrese M. Histological resolution of steatohepatitis after iron depletion. Dig Dis Sci. 2004;49:1012-5. PMID: 15309893.

  106. Soza A. Hepatitis tóxica: Acetaminofeno y otras. Gastr Latinoam. 2004;15:158-162.

  107. Promrat K, Lutchman G, Uwaifo GI, Freedman RJ, Soza A, Heller T, Doo E, Ghany M, Premkumar A, Park Y, Liang TJ, Yanovski JA, Kleiner DE, Hoofnagle JH. A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis. Hepatology. 2004;39:188-96. PMID: 14752837.

  108. Soza A, Hoofnagle JH. Mortality rate during interferon alfa-ribavirin combination therapy of chronic hepatitis C. (Letter). Hepatology. 2003;38:267. PMID: 12830010.

  109. Hoofnagle JH, Ghany MG, Kleiner DE, Doo E, Heller T, Promrat K, Ong J, Khokhar F, Soza A, Herion D, Park Y, Everhart JE, Liang TJ. Maintenance therapy with ribavirin in patients with chronic hepatitis C who fail to respond to combination therapy with interferon alfa and ribavirin. Hepatology. 2003;38:66-74. PMID: 12829988.

  110. Promrat K, McDermott DH, Gonzalez CM, Kleiner DE, Koziol DE, Lessie M, Merrell M, Soza A, Heller T, Ghany M, Park Y, Alter HJ, Hoofnagle JH, Murphy PM, Liang TJ. Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C. Gastroenterology. 2003;124:352-360. PMID: 12557141.

  111. Soza A, Lau DT, Khokhar MF, Conjeevaram H, Park Y, Hoofnagle JH. Resolution of chronic hepatitis B-associated autoimmune neutropenia with alpha interferon therapy. J Pediatr Gastroenterol Nutr. 2003;36:141-3. PMID: 12500011.

  112. Soza A, Everhart J, Ghany M, Doo E, Heller T, Promrat K, Park Y, Liang J, Hoofnagle JH. Neutropenia associated with alpha interferon therapy of chronic hepatitis C. Hepatology. 2002;36:1273-1279. PMID: 12395340.

  113. Soza A, Riquelme F, Álvarez M, Duarte I, Arrese M. Hepatotoxicity by amoxicillin-clavulanic acid: Case report and review. Rev Med Chil. 127(12):1487-1491,1999. PMID: 10835757.

  114. Martínez A, Muñoz V, Lisboa C, Jalil J, Godoy I, Moreno R, Ferretti R, Casanegra P, Saldías F, Guarda E, Corbalán R, Arroyo C, Soza A, Morales RA, Pozo I, Arancibia C. Non-invasive intermittent mechanical ventilation: usefulness in treatment of chronic severe heart failure. Rev Med Chil. 1995;123:1467-75. PMID: 8733263.

  115. Enríquez R, Escalona J, Oyarzún E, Chuaqui R, Soza A, Contreras G. Complicated placental chorioangioma: infrequent cause of premature labor. Rev Chil Obstet Ginecol. 1994;59:390-2. PMID: 7569157.

  116. Martínez A, Fajuri A, Corbalán R, Marchant E, Dussaillant E, Castellón J, Sanhueza G, Zepeda S, Arroyo C, Soza A. Incidence and features of cardiogenic shock in AMI: a comparison of the pre and post thrombolytic periods. Rev Chil Card. 1993;12:116-8.